Your Notifications
All done, no notifications

What is Biliary Atresia?

Biliary atresia is a rare and serious liver disease in which the bile ducts outside the liver become damaged, narrowed, or completely blocked. As a result, bile cannot flow normally from the liver into the intestine and instead builds up in the liver. This can cause progressive liver damage, scarring, and eventually cirrhosis if not treated. Biliary atresia usually becomes apparent during the first weeks of life and requires prompt evaluation by a pediatric hepatology or pediatric surgery team.

What is the Importance of Timely Treatment?

Timely diagnosis and treatment are essential because ongoing bile obstruction can rapidly damage the liver. The primary surgical treatment, the Kasai portoenterostomy, is generally most effective when performed early in infancy. Some children may continue to develop progressive liver disease despite surgery and may eventually require liver transplantation. Early treatment and specialist follow-up can improve the chances of maintaining liver function and supporting normal growth and development.

What are the Common Symptoms of Biliary Atresia?

  • Persistent jaundice or yellowing of the skin and eyes
  • Pale, white, grey or clay-coloured stools
  • Dark urine
  • Enlarged liver
  • Poor weight gain or slow growth
  • Feeding difficulties
  • Irritability
  • Abdominal swelling
  • Poor absorption of nutrients and fat-soluble vitamins
  • Signs of progressive liver disease in advanced cases

Causes and Risk Factors of Biliary Atresia

Causes

  • The exact cause of biliary atresia is not fully understood. It is thought to involve abnormal injury or inflammation of the bile ducts during early development or shortly after birth.
  • Proposed mechanisms include immune-mediated injury, viral or other infectious triggers, genetic susceptibility and abnormalities in bile duct development. In most infants, clinicians cannot identify a single definitive cause.

Risk Factors

  • Certain congenital or developmental abnormalities
  • Rare genetic susceptibility
  • Some congenital malformations associated with syndromic biliary atresia
  • Abnormal development of the bile ducts
  • Possible environmental or infectious factors, although no specific cause has been established for most cases

Latest Research and Technologies in the Treatment of Biliary Atresia in Turkey

  • Current research in biliary atresia focuses on improving early diagnosis, understanding the immune and inflammatory mechanisms of bile duct injury, improving outcomes after Kasai portoenterostomy, and optimising liver transplantation. Advances in neonatal and pediatric hepatology include improved assessment of cholestatic jaundice, abdominal ultrasound with Doppler, liver biopsy and specialised laboratory testing. Research is also examining biomarkers and molecular mechanisms that may help identify infants with biliary atresia earlier and predict response to Kasai surgery. Published research from Turkish centres has also examined outcomes of liver transplantation in children with biliary atresia, including comparisons between patients who underwent Kasai surgery and those who proceeded directly to transplantation.

Treatment options for Biliary Atresia

Kasai Portoenterostomy : The Kasai procedure is the primary surgical treatment for biliary atresia. The damaged extrahepatic bile ducts are removed, and a segment of intestine is connected to the liver to allow bile drainage.

Liver Transplantation : Liver transplantation may be required when Kasai surgery does not establish adequate bile drainage or when progressive liver failure, severe portal hypertension or other advanced complications develop.


Cost Start From 45000Explore Options

  • Clinical assessment:
    • Evaluation begins with a detailed history and physical examination, with particular attention to the onset and persistence of jaundice, stool colour, urine colour, feeding, growth and signs of liver enlargement.
    • Blood tests determine whether the infant has conjugated or direct hyperbilirubinemia and assess liver function. Liver biopsy may also be done (in infants).
    • Evaluation for infectious, metabolic and genetic causes of neonatal cholestasis when appropriate
    • Intraoperative cholangiography to confirm biliary atresia and assess the biliary anatomy
  • Imaging Tests:
    • Abdominal Ultrasound: Helps evaluate the liver, gallbladder and biliary system and may identify features suggestive of biliary atresia.
    • Doppler Ultrasound: Assesses blood flow in the portal and hepatic vessels and can help evaluate associated vascular abnormalities.
    • Hepatobiliary Scintigraphy (HIDA Scan): May be used in selected cases to assess bile flow, although it cannot independently confirm or exclude biliary atresia.
    • Magnetic Resonance Cholangiopancreatography (MRCP): May provide additional information about the hepatobiliary anatomy in selected infants.
    • Intraoperative Cholangiography: Considered an important diagnostic step during surgery and can confirm the absence or severe obstruction of the extrahepatic bile ducts.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Biliary Atresia patients in Turkey. These services include:

  • Growth and Development Monitoring: Regular assessment of weight, height, feeding and developmental milestones helps identify nutritional or developmental concerns early.
  • Post-Surgical Recovery Support: Infants require careful monitoring after Kasai surgery, including wound care, feeding support, infection surveillance and gradual return to normal activity.
  • Long-Term Liver and Transplant Follow-Up: Children require ongoing monitoring of liver function, nutritional status and complications of chronic liver disease, with transplant evaluation when clinically indicated.
  • Medicines do not correct the underlying biliary obstruction, so surgery remains central to treatment. Depending on the infant's condition, medicines may include antibiotics for suspected or confirmed cholangitis, medicines to support bile flow, and vitamin supplementation to correct deficiencies, which may be included in selected patient. Nutritional supplementation may include specialised formulas or medium-chain triglyceride-based nutrition when fat absorption is impaired. Additional medicines may be required to manage complications such as itching, ascites or portal hypertension. Medication selection should be guided by a pediatric hepatology or transplant specialist.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Biliary Atresia in Turkey

I.A.U VM Medical Park Florya Hospital: Top Doctors, and Reviews
I.A.U VM Medical Park Florya Hospital

Istanbul, Turkey

I.A.U VM Medical Park Florya Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • Situated on an area of 51.000 m2
  • Capacity of 300 beds
  • 13 Operating rooms
  • 92 Polyclinics
  • Emergency Unit
  • Intensive care Unit
  • Parking lots
  • Places of worship
  • Rooms designed according to different needs offer the comfort of a 5-star hotel
  • Special services are provided in all rooms, from television with domestic and foreign channels to internet service, from patient-specific diet menu to newspaper and magazine service
  • Cafe/Restaurant with delicious menu
Message Us
Medical Park Bahcelievler Hospital: Top Doctors, and Reviews
Medical Park Bahcelievler Hospital

Istanbul, Turkey

Medical Park Bahcelievler Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • Covers an area of 33.000 m
  • 19-storey Hospital Building
  • Capacity for 242 beds
  • 89 Outpatient clinic rooms
  • 10 Operating rooms
  • 24 Newborn Incubators
  • 6 Paediatric Intensive Care Beds
  • 28 Adult Intensive Care beds
  • 6 CVS and 12 cardiology intensive care beds
  • Luxurious & comfortable rooms like of 5-star hotel rooms for patients
  • Free Wi-fi
  • Parking lot
  • Place of worship
  • Cafe/Restaurant
Message Us
Medipol Mega University Hospital: Top Doctors, and Reviews
Medipol Mega University Hospital

Istanbul, Turkey

Medipol Mega University Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • The Hospital includes 4 centers i.e. general surgery, cardiovascular surgery, oncology, and dentistry
  • Medipol patients have access to over 60,000 m2 of the gardens, 26,000 m2 of the five-storied underground parking, 100,000 m2 covered premises and 1,500 members of the stuff
  • Capacity of 470 patient beds
  • Oncology Center
  • Emergency department that can admit up to 134 patients (including general, coronary, KVC and neonatal emergency department)
  • 25 Operating rooms
  • Medipol Mega University Hospital uses the following innovative technologies- Biplane digital flat-panel angiographic system, Digital flat-panel tomosynthetic mammography, Surgical O-ARM PEROP CT Imaging system, etc.
  • Helicopters enabling the transfer of the patient at the most emergency cases
  • The Hospital creates a friendly & comfortable ambience for the patients and their relatives with terrace garden suites, normal rooms. Each room is equipped with multimedia services like TV, DVD, Internet, online access from patients bedside, Unlimited Digital Archive pacs and high-quality meal service
  • Prayer Room
  • 5-starred cafeteria/restaurant
Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Turkey for Biliary Atresia Treatment?

  • Specialised Pediatric Liver Care: Major centres may offer multidisciplinary teams including pediatric hepatologists, pediatric surgeons, gastroenterologists, and transplant specialists.
  • Advanced Diagnostic Facilities: Hospitals may offer specialised laboratory testing, pediatric ultrasound with Doppler, liver biopsy and intraoperative cholangiography for accurate evaluation.
  • Experienced Pediatric Surgery: Selected centres perform Kasai portoenterostomy and other complex hepatobiliary procedures in infants.
  • Liver Transplantation Services: Children who develop advanced liver disease may have access to specialised pediatric liver-transplant programmes.
  • Comprehensive Pediatric Support: Nutritional care, infection management, developmental monitoring and international-patient coordination can be integrated into the treatment pathway.

Frequently Asked Questions

Recovery varies depending on the infant's age at treatment, liver condition and response to Kasai surgery. Hospital recovery after surgery may take several weeks, while monitoring of liver function, nutrition and growth continues for years. Children who require liver transplantation have a separate recovery and follow-up pathway.

Some children achieve good growth and development with timely treatment and appropriate nutritional support. Outcomes vary depending on liver function, complications and whether transplantation is required.

Major pediatric centres in Turkey may provide advanced liver-function testing, pediatric hepatobiliary imaging, Kasai portoenterostomy, intensive nutritional support and pediatric liver transplantation for appropriately selected patients.

Many major Turkey hospitals have international-patient departments that can assist families with medical records, specialist appointments, treatment coordination, travel arrangements, accommodation and follow-up care.

Look for a centre with experience in pediatric hepatology and pediatric hepatobiliary surgery, plus access to pediatric intensive care, nutrition specialists, and liver transplantation when needed. Experience with Kasai portoenterostomy and long-term management of biliary atresia is particularly important.

The success rate with children with biliary atresia depends on the infant's age at Kasai surgery, the extent of liver damage, anatomy, postoperative bile drainage, the development of cholangitis, and other factors. Some children maintain useful liver function after Kasai surgery, while others eventually require liver transplantation.

Pediatric hepatologists, pediatric surgeons and liver-transplant teams in specialised Turkey centres manage biliary atresia and its complications. Families should assess a centre's experience with Kasai surgery, pediatric liver disease and transplantation when needed.

Risks depend on the treatment and the child's overall condition. Kasai surgery may be associated with bleeding, infection, bile-related complications, cholangitis or inadequate bile drainage. Children with progressive liver disease may develop portal hypertension, ascites, nutritional deficiencies or liver failure and may require transplantation.

Persistent jaundice in an infant, especially when accompanied by pale stools or dark urine, requires prompt evaluation by a pediatrician or pediatric hepatology team. Early assessment matters because treatment outcomes are closely tied to timely diagnosis and management.

Prolonged liver disease, nutritional deficiencies or complications of advanced liver disease can affect growth and development if not appropriately managed.

Yes. Biliary atresia can affect nutrition, growth, energy levels, hospitalisation needs and daily life. Children who require long-term liver care or transplantation may need ongoing medical monitoring, although appropriate treatment and supportive care can help children achieve good functional development.

Untreated biliary atresia can lead to progressive liver fibrosis and cirrhosis, portal hypertension, nutritional deficiencies, liver failure and other serious complications. Because the disease can progress rapidly in infancy, early diagnosis and treatment are essential.

The exact cause is not fully understood, and most cases are not linked to a preventable parental or environmental factor. Early recognition of persistent infant jaundice and prompt medical evaluation are important for improving outcomes.

Biliary atresia is a rare disorder that occurs worldwide. It is more commonly recognised in certain populations and geographic regions, but the reasons for these differences are not fully understood. Most affected infants have no identifiable family history or specific preventable risk factor.

Author

Dr. Shagufta Parveen
Dr. Shagufta Parveen

Doctor of Pharmacy

3 Years of Experience

Dr. Shagufta Parveen is a Clinical researcher and medical writer with expertise in clinical pharmacology and pharmacotherapeutics. She holds a B.Pharm and Doctor of Pharmacy (Post-Baccalaureate) degree from Teerthanker Mahaveer University, Moradabad.

During her clinical stint at BLK-Max Super Speciality Hospital and Indraprastha Apollo Hospital, she gained hands-on experience in the Clinical Pharmacology Department. Combining scientific knowledge with strong medical writing skills, Dr. Shagufta develops evidence-based healthcare content, treatment guides, and patient education resources.

Her work focuses on simplifying complex medical concepts while maintaining scientific accuracy, helping readers better understand healthcare advancements and treatment options.

In addition to her writing expertise, she is actively involved in scientific research and has contributed to peer-reviewed publications.

Her research work is accessible through the following links:

https://scholar.google.com/citations?user=lMVK1eIAAAAJ&hl=en

https://carcinogenesis.com/index.php/JOC/article/view/870

https://carcinogenesis.com/index.php/JOC/article/view/868

https://wjpsronline.com/abstract/0000000760

View More

Reviewer

Dr. Akash Khandelwal
Dr. Akash Khandelwal

Hematologist

9 Years of Experience

Dr. Akash Khandelwal is a distinguished Hematologist, Hemato-oncologist, and Bone Marrow Transplant (BMT) Physician with extensive training from the prestigious AIIMS New Delhi. His expertise encompasses a wide range of specialized techniques in bone marrow transplantation, including autologous and allogeneic transplants such as matched sibling donors, matched unrelated donors (MUD), and haploidentical donor transplants. Dr. Khandelwal has personally supervised and conducted over 100 bone marrow transplants. View More

Last Reviewed - January 2026